670P Phase I trial of the delta-like ligand-3 (DLL3)/CD3 IgG-Like T cell engager BI 764532 in patients (pts) with DLL3-positive tumors: Updated data
| Autor: | Wermke, M., Gambardella, V., Kuboki, Y., Felip, E., Sanmamed, M.F., Alese, O., Sayehli, C.M., Arriola Aperribay, E., Wolf, J., Villaruz, L., Studeny, M., Bouzaggou, M., Fang, X., Morgensztern, D. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S525-S526 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|